MARKET

SPTX

SPTX

SEAPORT THERAPEUTICS INC
NASDAQ
20.83
+0.22
+1.07%
After Hours: 20.83 0 0.00% 19:30 10/26 EDT
OPEN
20.76
PREV CLOSE
20.61
HIGH
21.69
LOW
20.34
VOLUME
124.69K
TURNOVER
--
52 WEEK HIGH
28.38
52 WEEK LOW
14.85
MARKET CAP
1.12B
P/E (TTM)
-12.6357
1D
5D
1M
3M
1Y
5Y
1D
Seaport Therapeutics (SPTX) Presents Phase 1 GlyphAgo Data, Is The 44% Undervalued View Still Credible?
Simply Wall St · 3d ago
Weekly Report: what happened at SPTX last week (1012-1016)?
Weekly Report · 10/19 10:32
Canaccord Genuity Initiates Coverage of Seaport Therapeutics with Buy Rating
NASDAQ · 10/14 18:16
This Entegris Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Benzinga · 10/14 12:30
Seaport Therapeutics Price Target Announced at $28.00/Share by Canaccord Genuity
Dow Jones · 10/14 12:22
Canaccord Genuity Initiates Coverage On Seaport Therapeutics with Buy Rating, Announces Price Target of $28
Benzinga · 10/14 12:14
Seaport Therapeutics initiated with a Buy at Canaccord
TipRanks · 10/14 09:30
Wall Street Analysts Are Bullish on Top NA Picks
TipRanks · 10/12 13:50
More
About SPTX
Seaport Therapeutics, Inc. is a clinical-stage therapeutics company. The Company is focused on inventing and developing new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. Its product candidate, GlyphAllo (SPT-300 or Glyph Allopregnanolone), is a novel, Glyphed oral prodrug of allopregnanolone, an endogenous molecule that has been clinically validated in third-party trials for the treatment of postpartum depression. GlyphAgo (SPT-320 or Glyph Agomelatine), is a novel, Glyphed oral prodrug of agomelatine, a clinically validated anxiolytic and antidepressant that is approved for the treatment of generalized anxiety disorder. It is also advancing Glyph2BLS (SPT-348 or Glyph 2-bromo-LSD), a novel, Glyphed oral prodrug of the non-hallucinogenic LSD analog 2-bromo-LSD, in preclinical studies for depressive disorders. GlyphAllo is designed to overcome the bioavailability limitations of allopregnanolone and be durable in MDD.

Webull offers Seaport Therapeutics stock information, including NASDAQ: SPTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SPTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SPTX stock methods without spending real money on the virtual paper trading platform.